发明申请
US20140024661A1 FUSED PYRIMIDINES AND SUBSTITUTED QUINAZOLINES AS INHIBITORS OF P97
有权
作为P97的抑制剂的FUSED PYRIMIDINES和取代的喹哪啶
- 专利标题: FUSED PYRIMIDINES AND SUBSTITUTED QUINAZOLINES AS INHIBITORS OF P97
- 专利标题(中): 作为P97的抑制剂的FUSED PYRIMIDINES和取代的喹哪啶
-
申请号: US13946795申请日: 2013-07-19
-
公开(公告)号: US20140024661A1公开(公告)日: 2014-01-23
- 发明人: Han-Jie Zhou , Francesco Parlati
- 申请人: Han-Jie Zhou , Francesco Parlati
- 申请人地址: US CA Burlingame
- 专利权人: Cleave Biosciences, Inc.
- 当前专利权人: Cleave Biosciences, Inc.
- 当前专利权人地址: US CA Burlingame
- 主分类号: C07D403/04
- IPC分类号: C07D403/04 ; C07D471/04 ; C07D487/04 ; C07D405/04 ; C07D473/34 ; C07D495/04 ; C07D491/052 ; C07D513/04 ; C07D491/048
摘要:
A group of fused two ring pyrimidine compounds having a heterocycles substituent at the 2 position and a substituted amine at the 4 position as well as optional aliphatic, functional and/or aromatic components substituted at other positions of the pyrimidine and other ring are disclosed. In addition a group of quinazoline compounds having similar substituents at the 2 and 4 positions as well as at other positions are disclosed. These compounds are inhibitors of the AAA proteasome complex containing p97 and are effective medicinal agents for treatment of diseases associated with p97 bioactivity.
公开/授权文献
信息查询